When ¿old¿ lipid lowering therapies not should be discontinued Francesco Sbrana; Beatrice Dal Pino;

PCSK9 inhibitors tug of war: Compliance, adverse events and LDL-cholesterol target Francesco Sbrana; Beatrice Dal Pino;

Situation in 2020 of the requirements for the use of PCSK9 inhibitors in Spain: Results of a national survey Carlos Guijarro; Fernando Civeira; José López-Miranda; Luis Masana; Juan Pedro-Botet; Xavier Pintó; Pedro Valdivielso; José María Mostaza;